Clicky

Depression

Depression and anxiety among first-year college students worsen during pandemic

CHAPEL HILL, N.C. – First-year college students are reporting symptoms of depression and anxiety significantly more often than they were before the coronavirus pandemic, according to a study by the University of North Carolina at Chapel Hill. The study, embargoed for release until March 3, 2021, at 2 p.m. EST, in the journal PLOS ONE,

Depression and anxiety among first-year college students worsen during pandemic Read More »

More under-30 Americans report anxiety, depression during pandemic – CDC

(Reuters) – More young adults in the United States reported feeling anxious or depressed during the past six months of the COVID-19 pandemic, and fewer people reported getting the help they needed, according to a U.S. government study released on Friday. The percentage of adults under age 30 with recent symptoms of an anxiety or

More under-30 Americans report anxiety, depression during pandemic – CDC Read More »

On Nature column: Flatwoods depression vital to Indiana fauna | Columns

One of our most characteristic and productive wetland types in central Indiana is the flatwoods depression. These wetlands occur in flat uplands of the glacial till plain. Although soil classifications may vary by county, this community is often associated with Brookston soils, a silty clay loam soil with low permeability. The soils tend to pond

On Nature column: Flatwoods depression vital to Indiana fauna | Columns Read More »

Depression Increased as Physical Activity Decreased During COVID-19 Pandemic

The COVID-19 pandemic has impacted exercise in a number of ways. Gyms closed, sports were cancelled, and stress rose. In absence of routine, many began to get creative in their exercise programs, working out at home. However, new research shows a decrease in exercise could be leading to a significant increase in depression rates and

Depression Increased as Physical Activity Decreased During COVID-19 Pandemic Read More »

Sage Therapeutics Announces Promising Zuranolone Phase 3 Findings for Major Depression

New phase 3 open-label data show investigative therapy zuranolone may be eligible, in 2 dose forms, as a fast-acting, as-needed therapy for the treatment for major depressive disorder (MDD). The findings from the phase 3 SHORELINE study complement a building clinical portfolio for the two-week oral treatment, which Sage Therapeutics aims to result in the

Sage Therapeutics Announces Promising Zuranolone Phase 3 Findings for Major Depression Read More »

Maternal depressive and anxiety symptoms before and during the COVID-19 pandemic in Canada: a longitudinal analysis

Summary Background Parents have faced substantial social and economic challenges during the COVID-19 pandemic. Preliminary cross-sectional research has demonstrated increases in mental health problems in mothers during the COVID-19 pandemic compared with pre-pandemic estimates. We aimed to study an existing longitudinal cohort of mothers to assess changes in the prevalence of maternal depression and anxiety

Maternal depressive and anxiety symptoms before and during the COVID-19 pandemic in Canada: a longitudinal analysis Read More »

[Full text] The Association of Insomnia with Depression and Anxiety Symptoms in Pa

Introduction Sleep problems are serious, damaging comorbidities.1 They can influence mood and emotional or behavioral states and are complicated in psychopathology. Significantly strong partial associations of sleep disturbance with anxiety, depression, and insomnia, and a modest partial association with sleepiness have been detected.2 Insomnia is one of the most common sleep disorders and a known

[Full text] The Association of Insomnia with Depression and Anxiety Symptoms in Pa Read More »